Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hydrochloride, Levalbuterol
2. Hydrochloride, Levosalbutamol
3. Levalbuterol
4. Levosalbutamol Hydrochloride
5. Xopenex
1. 50293-90-8
2. Levalbuterol Hcl
3. Xopenex
4. (r)-albuterol Hydrochloride
5. Levosalbutamol Hydrochloride
6. R-albuterol Hydrochloride
7. (r)-salbutamol Hydrochloride
8. Levalbuterol Hydrochloride [usan:usp]
9. Nsc-759255
10. Albuterol Hydrochloride, R-
11. Wdq1526qjm
12. (r)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol Hydrochloride
13. (r)-albuterol
14. 50293-90-8(hcl)
15. 148563-16-0
16. Alfa1-[[1,1-dimethylethylamino]methyl]-4-hydroxy-1-(s),3-benzene Dimethanol Hydrochlorid
17. (-)-salbutamol Hydrochloride
18. Zopenex
19. Levalbuterol Hydrochloride [usan]
20. Unii-wdq1526qjm
21. (r)-4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol Hydrochloride
22. Xopenex (tn)
23. Zopenex [common Misspelling Of Xopenex]
24. Salbutamol (hydrochloride)
25. Schembl40682
26. Chembl1201061
27. Albuterol (r)-form Hydrochloride
28. Levalbuterol Hydrochloride (usp)
29. Dtxsid20198296
30. Pharmakon1600-01505811
31. Bcp04477
32. Ccg-39986
33. Mfcd08067728
34. Nsc759255
35. Akos015961919
36. (r)-salbutamol ((r)-albuterol Hcl)
37. Bs-1006
38. Nsc 759255
39. (r)-alpha(sup 1)-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol Hydrochloride
40. 4-[(1r)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol Hydrochloride
41. 1,3-benzenedimethanol, Alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, Hydrochloride, (alpha1r)-
42. 2-(hydroxymethyl)-4-{(1r)-1-hydroxy-2-[(2-methyl-2-propanyl)amino ]ethyl}phenol Hydrochloride (1:1)
43. Ac-23919
44. Levalbuterol Hydrochloride [usp-rs]
45. Levalbuterol Hydrochloride, >=98% (hplc)
46. Levosalbutamol Hydrochloride [mart.]
47. Levosalbutamol Hydrochloride [who-dd]
48. Albuterol (r)-form Hydrochloride [mi]
49. D02281
50. Levalbuterol Hydrochloride [orange Book]
51. 293l908
52. A928075
53. Levalbuterol Hydrochloride [usp Monograph]
54. Q27292577
55. 4-[(1r)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;hydrochloride
56. Alfa1-[[1,1-dimethylethylamino]methyl]-4-hydroxy-1-(s),3-benzenedimethanolhydrochlorid
57. Levalbuterol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
58. (r)-.alpha.(sup 1)-((tert-butylamino)methyl)-4-hydroxy-m-xylene-.alpha.,.alpha.'-diol Hydrochloride
Molecular Weight | 275.77 g/mol |
---|---|
Molecular Formula | C13H22ClNO3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 275.1288213 g/mol |
Monoisotopic Mass | 275.1288213 g/mol |
Topological Polar Surface Area | 72.7 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 227 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levalbuterol hydrochloride |
Drug Label | Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selectiv... |
Active Ingredient | Levalbuterol hydrochloride |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.021% base; eq 0.25% base; eq 0.0103% base; eq 0.042% base |
Market Status | Prescription |
Company | Teva Parenteral; Teva Pharms Usa; Mylan Speclt; Cipla; Watson Labs |
2 of 2 | |
---|---|
Drug Name | Levalbuterol hydrochloride |
Drug Label | Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selectiv... |
Active Ingredient | Levalbuterol hydrochloride |
Dosage Form | Solution |
Route | Inhalation |
Strength | eq 0.021% base; eq 0.25% base; eq 0.0103% base; eq 0.042% base |
Market Status | Prescription |
Company | Teva Parenteral; Teva Pharms Usa; Mylan Speclt; Cipla; Watson Labs |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
About the Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international ma...
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
About the Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cyto...
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Beijing Breathgreen Healthcare Co. Ltd was established in 2008. The company has extensive experience in developing high-quality API products for inhalation formulation and providin...
About the Company : Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission i...
About the Company : Hunan Warrant Pharmaceutical Co., Ltd. is a high-tech joint-stock company founded in 2001. With 3 production bases and 2 R&D center, which is engaged in manufacture & supply of API...
About the Company : Jayco Chemical Industries is one of the fastest growing manufacturers and exporters of Active Pharmaceutical Ingredients and advanced intermediates dealing in Anti-Asthmatics, Vaso...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Levalbuterol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levalbuterol Hydrochloride, including repackagers and relabelers. The FDA regulates Levalbuterol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levalbuterol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levalbuterol Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levalbuterol Hydrochloride supplier is an individual or a company that provides Levalbuterol Hydrochloride active pharmaceutical ingredient (API) or Levalbuterol Hydrochloride finished formulations upon request. The Levalbuterol Hydrochloride suppliers may include Levalbuterol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Levalbuterol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levalbuterol Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Levalbuterol Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Levalbuterol Hydrochloride DMFs exist exist since differing nations have different regulations, such as Levalbuterol Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levalbuterol Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Levalbuterol Hydrochloride USDMF includes data on Levalbuterol Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levalbuterol Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levalbuterol Hydrochloride suppliers with USDMF on PharmaCompass.
A Levalbuterol Hydrochloride written confirmation (Levalbuterol Hydrochloride WC) is an official document issued by a regulatory agency to a Levalbuterol Hydrochloride manufacturer, verifying that the manufacturing facility of a Levalbuterol Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levalbuterol Hydrochloride APIs or Levalbuterol Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Levalbuterol Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Levalbuterol Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levalbuterol Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levalbuterol Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levalbuterol Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levalbuterol Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levalbuterol Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levalbuterol Hydrochloride suppliers with NDC on PharmaCompass.
Levalbuterol Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levalbuterol Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levalbuterol Hydrochloride GMP manufacturer or Levalbuterol Hydrochloride GMP API supplier for your needs.
A Levalbuterol Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Levalbuterol Hydrochloride's compliance with Levalbuterol Hydrochloride specifications and serves as a tool for batch-level quality control.
Levalbuterol Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Levalbuterol Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levalbuterol Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Levalbuterol Hydrochloride EP), Levalbuterol Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levalbuterol Hydrochloride USP).
LOOKING FOR A SUPPLIER?